APAC Lung Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	273 Pages	Data Bridge Market Research	November, 2022	DAABD17583253

Best Price Guarantee
Price	from $3,500
Length	273 Pages
Publisher	Data Bridge Market Research
Published Date	November, 2022
SKU	DAABD17583253

APAC Lung Cancer Diagnostics Market - Industry Trends and Forecast to 2030

The Asia-Pacific lung cancer diagnostics market is projected to register a substantial CAGR of 16.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030

Market Segmentation

Asia-Pacific Lung Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Biomarkers Test, Imaging Test, Biopsy, Blood Test, and Others), Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), End User (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Asia-Pacific lung cancer diagnostics market are:
• Rise in prevalence and incidence of lung cancer
• Increase in awareness about the lung cancer diagnostics
Market Players
Some of the major players operating in the Asia-Pacific lung cancer diagnostics market are:

• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott
• Quest Diagnostics Incorporated
• Amoy Diagnostics Co., Ltd.
• Bio-Rad Laboratories, Inc.
• Biocartis
• Boditech Med Inc.
• Danaher
• Vela Diagnostics
• DiaSorin S.p.A.
• Exact Sciences UK, Ltd. (a subsidiary of Exact Science Corporation)
• LalPathLabs.com
• MedGenome
• Myriad Genetics, Inc.
• NeoGenomics Laboratories
• NanoString
• Nanoentek
• PerkinElmer Inc.
• PlexBio
• QIAGEN
• Siemens Healthcare GmbH

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Asia Pacific Lung Cancer Diagnostics Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Product Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market Testing Type Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Porter’s Five Forces; 4.2 Pestel Analysis; 4.3 Industry Insights
5 Epidermiology
6 Regulations
7 Market Overview: 7.1 Drivers; 7.1.1 Unmet Need For Non-invasive, Accurate, And Reliable Diagnostic Tests For Earlier Cancer Detection; 7.1.2 Increasing Early Diagnosis Of Lungs Cancer; 7.1.3 Increasing Cases Of Lung Cancer; 7.1.4 Rise In Product Approvals; 7.2 Restraints; 7.2.1 Poor & Late Diagnosis Of Lung Cancer; 7.2.2 High False-positives And Poor Sensitivity; 7.3 Opportunities; 7.3.1 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment; 7.3.2 Government Initiatives Toward Cancer Diagnostics; 7.3.3 Rising Awareness Of Lung Cancer; 7.4 Challenges; 7.4.1 Stringent Regulatory Framework For The Approval And Commercialization Of Cancer Diagnostic Products; 7.4.2 Increased Cost, Safety, And Convenience Issues; 7.4.3 Lack Of Skilled And Certified Professionals
8 Asia Pacific Lung Cancer Diagnostics Market, By Product Type: 8.1 Overview; 8.2 Instruments; 8.2.1 Imaging Instruments; 8.2.1.1 Ct Systems; 8.2.1.2 Ultrasound Systems; 8.2.1.3 Mri Systems; 8.2.1.4 Others; 8.2.2 Biopsy Instruments; 8.2.2.1 Needle Biopsy; 8.2.2.2 Endoscopic Biopsy; 8.2.2.3 Core Biopsy; 8.2.2.4 Others; 8.2.3 Pathology-based Instruments; 8.2.3.1 Slide Staining Systems; 8.2.3.2 Tissue Processing Systems; 8.2.3.3 Cell Processors; 8.2.3.4 Pcr Instruments; 8.2.3.5 Others Pathology-based Instruments; 8.3 Consumables And Accessories; 8.3.1 Kits; 8.3.1.1 Dna Polymerase Kits; 8.3.1.2 Nucleic Acid Isolation Kits; 8.3.1.3 Pcr Kits; 8.3.1.4 Others; 8.3.2 Reagents; 8.3.2.1 Assays; 8.3.2.2 Buffers; 8.3.2.3 Primers; 8.3.2.4 Others; 8.3.3 Probes; 8.3.4 Other Consumables
9 Asia Pacific Lung Cancer Diagnostics Market, By Test Type: 9.1 Overview; 9.2 Imaging Test; 9.2.1 Computed Tomography (Ct) Scan; 9.2.2 Positron Emission Tomography (Pet) Scan; 9.2.3 Chest X-ray; 9.2.4 Bone Scan; 9.2.5 Mri; 9.2.6 Others; 9.3 Biomarkers Test; 9.3.1 Egfr Mutation Test; 9.3.2 Kras Mutation Test; 9.3.3 Alk Test; 9.3.4 Her2 Test; 9.3.5 Others; 9.4 Biopsy; 9.4.1 Needle Biopsy; 9.4.2 Bronchoscopy Biopsy; 9.4.3 Core Biopsy; 9.4.4 Others; 9.5 Blood Test; 9.5.1 Complete Blood Count (Cbc); 9.5.2 Blood Chemistry Tests; 9.5.3 Others; 9.6 Others
10 Asia Pacific Lung Cancer Diagnostics Market, By Cancer Type: 10.1 Overview; 10.2 Non-small Cell Lung Cancer; 10.3 Small Cell Lung Cancer
11 Asia Pacific Lung Cancer Diagnostics Market, By End User: 11.1 Overview; 11.2 Hospital; 11.3 Associated Labs; 11.4 Independent Diagnostic Laboratories; 11.5 Diagnostic Imaging Centers; 11.6 Cancer Research Institutes; 11.7 Others
12 Asia Pacific Lung Cancer Diagnostics Market, By Distribution Channel: 12.1 Overview; 12.2 Direct Tender; 12.3 Retail Sales
13 Asia Pacific Lung Cancer Diagnostics Market, By Region: 13.1 Asia-pacific; 13.1.1 China; 13.1.2 Japan; 13.1.3 South Korea; 13.1.4 Australia; 13.1.5 India; 13.1.6 Singapore; 13.1.7 Indonesia; 13.1.8 Philippines; 13.1.9 Vietnam; 13.1.10 Malaysia; 13.1.11 Thailand; 13.1.12 New Zealand; 13.1.13 Taiwan; 13.1.14 Rest Of Asia-pacific
14 Asia Pacific Lung Cancer Diagnostics Market, Company Landscape: 14.1 Company Share Analysis: Asia Pacific
15 Swot Analysis
16 Company Profile: 16.1 F. Hoffmann-la Roche Ltd. (2022); 16.1.1 Company Snapshot; 16.1.2 Revenue Analysis; 16.1.3 Company Share Analysis; 16.1.4 Product Portfolio; 16.1.5 Recent Developments; 16.2 Thermo Fisher Scientific Inc. (2022); 16.2.1 Company Snapshot; 16.2.2 Revenue Analysis; 16.2.3 Company Share Analysis; 16.2.4 Product Portfolio; 16.2.5 Recent Developments; 16.3 Abbott (2022); 16.3.1 Company Snapshot; 16.3.2 Revenue Analysis; 16.3.3 Company Share Analysis; 16.3.4 Product Portfolio; 16.3.5 Recent Developments; 16.4 Quest Diagnostics Incorporated (2022); 16.4.1 Company Snapshot; 16.4.2 Revenue Analysis; 16.4.3 Company Share Analysis; 16.4.4 Product Portfolio; 16.4.5 Recent Developments; 16.5 Biodesix (2022); 16.5.1 Company Profile; 16.5.2 Revenue Analysis; 16.5.3 Company Share Analysis; 16.5.4 Product Portfolio; 16.5.5 Recent Developments; 16.6 Amoy Diagnostics Co., Ltd. (2022); 16.6.1 Company Snapshot; 16.6.2 Product Portfolio; 16.6.3 Recent Developments; 16.7 Bio-rad Laboratories, Inc. (2022); 16.7.1 Company Snapshot; 16.7.2 Revenue Analysis; 16.7.3 Product Portfolio; 16.7.4 Recent Developments; 16.8 Biocartis (2022); 16.8.1 Company Snapshot; 16.8.2 Revenue Analysis; 16.8.3 Product Portfolio; 16.8.4 Recent Developments; 16.9 Boditech Med Inc.; 16.9.1 Company Profile; 16.9.2 Product Portfolio; 16.9.3 Recent Developments; 16.10 Danaher (2022); 16.10.1 Company Snapshot; 16.10.2 Revenue Analysis; 16.10.3 Product Portfolio; 16.10.4 Recent Developments; 16.11 Diasorin S.P.A. (2022); 16.11.1 Company Snapshot; 16.11.2 Revenue Analysis; 16.11.3 Product Portfolio; 16.11.4 Recent Developments; 16.12 Exact Sciences Uk, Ltd. (Subsidiary Of Exact Science Corporation) (2022); 16.12.1 Company Snapshot; 16.12.2 Revenue Analysis; 16.12.3 Product Portfolio; 16.12.4 Recent Developments; 16.13 20/20 Gene Systems; 16.13.1 Company Profile; 16.13.2 Product Portfolio; 16.13.3 Recent Developments; 16.14 Guardant Health Inc.; 16.14.1 Company Profile; 16.14.2 Product Portfolio; 16.14.3 Recent Developments; 16.15 Inivata Ltd.; 16.15.1 Company Profile; 16.15.2 Product Portfolio; 16.15.3 Recent Developments; 16.16 Lalpathlabs.Com (2022); 16.16.1 Company Snapshot; 16.16.2 Revenue Analysis; 16.16.3 Product Portfolio; 16.16.4 Recent Developments; 16.17 Lunglife Ai, Inc. (2022); 16.17.1 Company Snapshot; 16.17.2 Product Portfolio; 16.17.3 Recent Developments; 16.18 Medgenome; 16.18.1 Company Snapshot; 16.18.2 Product Portfolio; 16.18.3 Recent Developments; 16.19 Myriad Genetics, Inc.; 16.19.1 Company Snapshot; 16.19.2 Product Portfolio; 16.19.3 Recent Developments; 16.20 Neogenomics Laboratories (2022); 16.20.1 Company Snapshot; 16.20.2 Revenue Analysis; 16.20.3 Product Portfolio; 16.20.4 Recent Developments; 16.21 Nanostring (2022); 16.21.1 Company Snapshot; 16.21.2 Revenue Analysis; 16.21.3 Product Portfolio; 16.21.4 Recent Developments; 16.22 Nanoentek; 16.22.1 Company Profile; 16.22.2 Product Portfolio; 16.22.3 Recent Developments; 16.23 Oncocyte Corporation; 16.23.1 Company Profile; 16.23.2 Service Portfolio; 16.23.3 Recent Developments; 16.24 Perkinelmer Inc; 16.24.1 Company Profile; 16.24.2 Revenue Analysis; 16.24.3 Product Portfolio; 16.24.4 Recent Developments 259
List Of Tables: Table 1 Different Types Of Cancer Screening Tests For Different Types Of Cancers; Table 2 Lung Cancer Rates; Table 3 Approved Diagnostics Of Lungs Cancer; Table 4 Asia Pacific Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 5 Asia Pacific Instruments In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 6 Asia Pacific Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 7 Asia Pacific Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 8 Asia Pacific Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 9 Asia Pacific Consumables & Accessories In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 10 Asia Pacific Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 11 Asia Pacific Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 12 Asia Pacific Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 13 Asia Pacific Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 14 Asia Pacific Imaging Test In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 15 Asia Pacific Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 16 Asia Pacific Biomarkers Test In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 17 Asia Pacific Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 18 Asia Pacific Biopsy In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 19 Asia Pacific Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 20 Asia Pacific Blood Test In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 21 Asia Pacific Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 22 Asia Pacific Others In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 23 Asia Pacific Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million); Table 24 Asia Pacific Non-small Cell Lung Cancer In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 25 Asia Pacific Small Cell Lung Cancer In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 26 Asia Pacific Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million); Table 27 Asia Pacific Hospital In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 28 Asia Pacific Associated Labs In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 29 Asia Pacific Independent Diagnostic Laboratories In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 30 Asia Pacific Diagnostic Imaging Centers In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 31 Asia Pacific Cancer Research Institutes In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 32 Asia Pacific Others In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 33 Asia Pacific Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million); Table 34 Asia Pacific Direct Tender In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 35 Asia Pacific Retail Sales In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million); Table 36 Asia-pacific Lung Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million); Table 37 Asia-pacific Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 38 Asia-pacific Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 39 Asia-pacific Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 40 Asia-pacific Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 41 Asia-pacific Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 42 Asia-pacific Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 43 Asia-pacific Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 44 Asia-pacific Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 45 Asia-pacific Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 46 Asia-pacific Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 47 Asia-pacific Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 48 Asia-pacific Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 49 Asia-pacific Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 50 Asia-pacific Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million); Table 51 Asia-pacific Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million); Table 52 Asia-pacific Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million); Table 53 China Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 54 China Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 55 China Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 56 China Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 57 China Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 58 China Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 59 China Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 60 China Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 61 China Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 62 China Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 63 China Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 64 China Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 65 China Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 66 China Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million); Table 67 China Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million); Table 68 China Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million); Table 69 Japan Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 70 Japan Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 71 Japan Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 72 Japan Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 73 Japan Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 74 Japan Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 75 Japan Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 76 Japan Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 77 Japan Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 78 Japan Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 79 Japan Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 80 Japan Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 81 Japan Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 82 Japan Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million); Table 83 Japan Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million); Table 84 Japan Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million); Table 85 South Korea Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 86 South Korea Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 87 South Korea Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 88 South Korea Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 89 South Korea Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 90 South Korea Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 91 South Korea Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 92 South Korea Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 93 South Korea Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 94 South Korea Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 95 South Korea Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 96 South Korea Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 97 South Korea Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 98 South Korea Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million); Table 99 South Korea Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million); Table 100 South Korea Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million); Table 101 Australia Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 102 Australia Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 103 Australia Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 104 Australia Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 105 Australia Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 106 Australia Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 107 Australia Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 108 Australia Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 109 Australia Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 110 Australia Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 111 Australia Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 112 Australia Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 113 Australia Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 114 Australia Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million); Table 115 Australia Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million); Table 116 Australia Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million); Table 117 India Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 118 India Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 119 India Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 120 India Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 121 India Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 122 India Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 123 India Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 124 India Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 125 India Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 126 India Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 127 India Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 128 India Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 129 India Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million); Table 130 India Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million); Table 131 India Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million); Table 132 India Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million); Table 133 Singapore Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 134 Singapore Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 135 Singapore Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 136 Singapore Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million); Table 137 Singapore Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million) 151
List Of Figures: Figure 1 Asia Pacific Lung Cancer Diagnostics Market: Segmentation; Figure 2 Asia Pacific Lung Cancer Diagnostics Market: Data Triangulation; Figure 3 Asia Pacific Lungs Cancer Diagnostics Market: Droc Analysis; Figure 4 Asia Pacific Lung Cancer Diagnostics Market: Asia Pacific Vs Regional Market Analysis; Figure 5 Asia Pacific Lung Cancer Diagnostic Market: Company Research Analysis; Figure 6 Asia Pacific Lung Cancer Diagnostics Market: Interview Demographics; Figure 7 Asia Pacific Lung Cancer Diagnostics Market: Dbmr Market Position Grid; Figure 8 Asia Pacific Lung Cancer Diagnostics Market: Market End User Coverage Grid; Figure 9 Asia Pacific Lung Cancer Diagnostics Market: Vendor Share Analysis; Figure 10 Asia Pacific Lung Cancer Diagnostics Market: Segmentation; Figure 11 The Increase In The Awareness About Lung Cancer Is Expected To Drive The Asia Pacific Lung Cancer Diagnostics Market In The Forecast Period; Figure 12 Instruments Segment Is Expected To Account For The Largest Share Of The Asia Pacific Lung Cancer Diagnostics Market In 2023 & 2030; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Asia Pacific Lung Cancer Diagnostics Market; Figure 14 The Asia Pacific Mortality Rate Due To Cancer; Figure 15 The Data Given Below Shows The Increasing Asia Pacific Cancer Rate In 2020; Figure 16 Barriers To Early Cancer Diagnosis And Treatment; Figure 17 Asia Pacific Lung Cancer Diagnostics Market: By Product Type, 2022; Figure 18 Asia Pacific Lung Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million); Figure 19 Asia Pacific Lung Cancer Diagnostics Market: By Product Type, Cagr (2023-2030); Figure 20 Asia Pacific Lung Cancer Diagnostics Market: By Product Type, Lifeline Curve; Figure 21 Asia Pacific Lung Cancer Diagnostics Market: By Test Type, 2022; Figure 22 Asia Pacific Lung Cancer Diagnostics Market: By Test Type, 2023-2030 (Usd Million); Figure 23 Asia Pacific Lung Cancer Diagnostics Market: By Test Type, Cagr (2023-2030); Figure 24 Asia Pacific Lung Cancer Diagnostics Market: By Test Type, Lifeline Curve; Figure 25 Asia Pacific Lung Cancer Diagnostics Market: By Cancer Type, 2022; Figure 26 Asia Pacific Lung Cancer Diagnostics Market: By Cancer Type, 2023-2030 (Usd Million); Figure 27 Asia Pacific Lung Cancer Diagnostics Market: By Cancer Type, Cagr (2023-2030); Figure 28 Asia Pacific Lung Cancer Diagnostics Market: By Cancer Type, Lifeline Curve; Figure 29 Asia Pacific Lung Cancer Diagnostics Market: By End User, 2022; Figure 30 Asia Pacific Lung Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million); Figure 31 Asia Pacific Lung Cancer Diagnostics Market: By End User, Cagr (2023-2030); Figure 32 Asia Pacific Lung Cancer Diagnostics Market: By End User, Lifeline Curve; Figure 33 Asia Pacific Lung Cancer Diagnostics Market: By Distribution Channel, 2022; Figure 34 Asia Pacific Lung Cancer Diagnostics Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 35 Asia Pacific Lung Cancer Diagnostics Market: By Distribution Channel, Cagr (2023-2030); Figure 36 Asia Pacific Lung Cancer Diagnostics Market: By Distribution Channel, Lifeline Curve; Figure 37 Asia-pacific Lung Cancer Diagnostics Market: Snapshot (2022); Figure 38 Asia-pacific Lung Cancer Diagnostics Market: By Country (2022); Figure 39 Asia-pacific Lung Cancer Diagnostics Market: By Country (2023 & 2030); Figure 40 Asia-pacific Lung Cancer Diagnostics Market: By Country (2022 & 2030); Figure 41 Asia-pacific Lung Cancer Diagnostics Market: By Product Type (2023-2030); Figure 42 Asia Pacific Lung Cancer Diagnostics Market: Company Share 2022 (%)